Treatment Indications: volumizing and structural contouring in deep subcutaneous and supraperiosteal layers;, correction of severe volume loss and deep facial depressions;, restoration of facial architecture and symmetry in cases of pronounced atrophy;, achieving a pronounced lifting effect via deep‑layer volumization (cheeks, temples, jawline)
Release form: 1 × 1.1 mL pre‑filled sterile syringe
Indications: volumizing and structural contouring in deep subcutaneous layers;, restoration of major volume deficits and facial skeletal support;, smoothing deep depressions and folds;, providing maximum shape retention, viscoelasticity, and lifting power with minimal migration (effect duration ~12–24 months)